Clinical Trial Update: Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating glimepiride for patients with type 2 diabetes mellitus and chronic heart failure with reduced ejection fraction; the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride) (glimepiride)

Snippet

Sponsor: Tongji Hospital | Conditions: Type 2 Diabetes Mellitus (T2DM), Chronic Heart Failure (CHF) | Phase 3 | Status: NOT_YET_RECRUITING